How effective are interventions to reduce Staphylococcus aureus (SA) in treating infected or non-infected atopic eczema?
Care should be taken in interpreting these results as failure to show benefit in a series of small, poorly reported studies does not mean that anti-staphylococcal interventions may not be helpful for eczema. It is clinical common sense to treat overtly infected eczema with oral antibiotics, and that practice should continue until good evidence suggests otherwise. However, given that none of the studies showed clear clinical benefit for anti-staphylococcal interventions in non-infected eczema, their continued use should be questioned in such circumstances.
Atopic eczema is a common problem, affecting around 15% of schoolchildren.¹ Symptoms usually appear before the age of two years and around 60% of cases will be clear of eczema by early adolescence.The skin of people with atopic eczema often contains high numbers of SA. Even when the eczema does not look infected, SA may still play a part in promoting skin inflammation. 1. Emerson RM et al. Br J Dermat 1998; 139:73-76.